Syngenta sees double-digit growth in biologicals in 2025, makes ‘no final decision’ on IPO

Syngenta revealed its full-year 2025 results, with biologicals remaining a hot growth area despite revenues slipping slightly year-over-year, as the ag giant is expected to IPO later this year.